Alnylam Pharmaceuticals
ALNY
#561
Rank
NZ$74.57 B
Marketcap
NZ$562.31
Share price
-0.94%
Change (1 day)
27.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company